{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:28:10Z","timestamp":1785407290554,"version":"3.56.0"},"reference-count":16,"publisher":"Sociedade Brasileira de Pneumologia e Tisiologia","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Bras. Pneumol."],"DOI":"10.36416\/1806-3756\/e20250449","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T21:20:34Z","timestamp":1768857634000},"page":"e20250449","source":"Crossref","is-referenced-by-count":0,"title":["Searching for alpha-1 antitrypsin deficiency in patients with bronchiectasis: reducing idiopathic cases"],"prefix":"10.36416","author":[{"given":"Sara","family":"Qutubuddin\u00b9","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01ckdn478","id-type":"ROR","asserted-by":"publisher"}],"name":"Universidad de Louisville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Cavallazzi\u00b9","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01ckdn478","id-type":"ROR","asserted-by":"publisher"}],"name":"Universidad de Louisville"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22288","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"1.           Shoemark A, Shteinberg M, De Soyza A, Haworth C, Richardson H, Gao Y, et al. Characterisation of Eosinophilic Bronchiectasis: A European Multicohort Study. Am J Respir Crit Care Med. 2022;205(8):894-902. https:\/\/doi.org\/10.1183\/13993003.congress-2021.OA1307","DOI":"10.1164\/rccm.202108-1889OC"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"2.           Mac Aog\u00e1in M, Narayana JK, Tiew PY, Ali N, Yong VFL, Jaggi TK, et al. Integrative microbiomics in bronchiectasis exacerbations. Nat Med. 2021;27(4):688-99. https:\/\/doi.org\/10.1038\/s41591-021-01289-7","DOI":"10.1038\/s41591-021-01289-7"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"3.           Dhar R, Singh S, Talwar D, Mohan M, Tripathi SK, Swarnakar R, et al. Bronchiectasis in India: results from the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory Research Network of India Registry. Lancet Glob Health. 2019;7(9):e1269-e1279. https:\/\/doi.org\/10.1016\/S2214-109X(19)30327-4","DOI":"10.1016\/S2214-109X(19)30327-4"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"4.           Athanazio R, Pereira MC, Gramblicka G, Cavalcanti-Lundgren F, de Figueiredo MF, Arancibia F, et al. Latin America validation of FACED score in patients with bronchiectasis: an analysis of six cohorts. BMC Pulm Med. 2017;17(1):73. https:\/\/doi.org\/10.1186\/s12890-017-0417-3","DOI":"10.1186\/s12890-017-0417-3"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"5.           Xu JF, Zheng HZ, Lu HW, Wang LW, Wu B, Lv XD, et al. Baseline characteristics of patients in the Chinese Bronchiectasis Registry (BE-China): a multicentre prospective cohort study. Lancet Respir Med. 2025;13(2):166-76. https:\/\/doi.org\/10.1016\/S2213-2600(24)00364-3","DOI":"10.1016\/S2213-2600(24)00364-3"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"6.           Chalmers JD, Polverino E, Crichton ML, Ringshausen FC, De Soyza A, Vendrell M, et al. Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC). Lancet Respir Med. 2023;11(7):637-49. https:\/\/doi.org\/10.1016\/S2213-2600(23)00093-0","DOI":"10.1016\/S2213-2600(23)00093-0"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"7.           Feitosa PHR, Castellano M, Costa CHD, Cardoso A, Pereira LFF, Fernandes FLA, et al. Recommendations for the diagnosis and treatment of alpha-1 antitrypsin deficiency. J Bras Pneumol. 2024;50(5):e20240235. https:\/\/doi.org\/10.36416\/1806-3756\/e20240235","DOI":"10.36416\/1806-3756\/e20240235"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"8.           Stockley RA, Pye A, De Soyza J, Turner AM, Miravitlles M. The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: initial report of EARCO. Orphanet J Rare Dis. 2023;18(1):243. https:\/\/doi.org\/10.1186\/s13023-023-02830-2","DOI":"10.21203\/rs.3.rs-2612082\/v1"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"9.           Felisbino MB, Fernandes FLA, Nucci M, Pinto RMC, Pizzichini E, Cukier A. The patient profile of individuals with Alpha-1 antitrypsin gene mutations at a referral center in Brazil. J Bras Pneumol. 2018;44(5):383-9. https:\/\/doi.org\/10.1590\/s1806-37562017000000420","DOI":"10.1590\/s1806-37562017000000420"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"10.        Lopez-Campos JL, Osaba L, Czischke K, Jardim JR, Fernandez Acquier M, Ali A, et al. Feasibility of a genotyping system for the diagnosis of alpha1 antitrypsin deficiency: a multinational cross-sectional analysis. Respir Res. 2022;23(1):152. https:\/\/doi.org\/10.1186\/s12931-022-02074-x","DOI":"10.1186\/s12931-022-02074-x"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"11.        Russo R, Zillmer LR, Nascimento OA, Manzano B, Ivanaga IT, Fritscher L, et al. Prevalence of alpha-1 antitrypsin deficiency and allele frequency in patients with COPD in Brazil. J Bras Pneumol. 2016;42(5):311-6. https:\/\/doi.org\/10.1590\/S1806-37562015000000180","DOI":"10.1590\/S1806-37562015000000180"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"12.        Sokoloski CS, Canan MGM, Leit\u00e3o CA, Storrer KM. Prevalence of SERPINA1 mutations in a bronchiectasis cohort: implications of extended screening for alpha-1 antitrypsin deficiency. J Bras Pneumol. 2025;51(5):e20250181. https:\/\/doi.org\/10.36416\/1806-3756\/e20250181","DOI":"10.36416\/1806-3756\/e20250181"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"13.        Chalmers JD, Haworth CS, Flume P, Long MB, Burgel PR, Dimakou K, et al. European Respiratory Society Clinical Practice Guideline for the Management of Adult Bronchiectasis. Eur Respir J. 2025: 2501126. https:\/\/doi.org\/10.1183\/13993003.01126-2025","DOI":"10.1183\/13993003.01126-2025"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"14.        Hill AT, Sullivan AL, Chalmers JD, De Soyza A, Elborn SJ, Floto AR, et al. British Thoracic Society Guideline for bronchiectasis in adults. Thorax. 2019;74(Suppl 1):1-69. https:\/\/doi.org\/10.1136\/thoraxjnl-2018-212463","DOI":"10.1136\/thoraxjnl-2018-212463"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"15.        Chang AB, Bell SC, Byrnes CA, Dawkins P, Holland AE, Kennedy E, et al. Thoracic Society of Australia and New Zealand (TSANZ) position statement on chronic suppurative lung disease and bronchiectasis in children, adolescents and adults in Australia and New Zealand. Respirology. 2023;28(4):339-49. https:\/\/doi.org\/10.1111\/resp.14479","DOI":"10.1111\/resp.14479"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"16.        Pereira MC, Athanazio RA, Dalcin PTR, Figueiredo MRF, Gomes M, Freitas CG, et al. Brazilian consensus on non-cystic fibrosis bronchiectasis. J Bras Pneumol. 2019;45(4):e20190122. https:\/\/doi.org\/10.1590\/1806-3713\/e20190122","DOI":"10.1590\/1806-3713\/e20190122"}],"container-title":["Jornal Brasileiro de Pneumologia"],"original-title":[],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T21:20:37Z","timestamp":1768857637000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jornaldepneumologia.com.br\/details\/4187\/en-US"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":16,"URL":"https:\/\/doi.org\/10.36416\/1806-3756\/e20250449","relation":{},"ISSN":["1806-3756"],"issn-type":[{"value":"1806-3756","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"article-number":"2025-0449"}}